BMJ4d
Guselkumab in Behçet’s disease
The mucocutaneous and articular clinical phenotype is the most common presentation of Behçet’s disease (BD).1 Current ...
BMJ10h
Acyltransferase skinny hedgehog regulates TGFβ-dependent fibroblast activation in SSc
Correspondence to Dr Jörg H W Distler, Department of Internal Medicine III, University of Erlangen, Erlangen D-91054, Germany; joerg.distler{at}uk-erlangen.de Objectives Systemic sclerosis (SSc) is ...
BMJ1d
Ankylosing Spondylitis Disease Activity Score (ASDAS): defining cut-off values for disease activity states and improvement scores
2 Rheumatology Department, Leiden University Medical Center, Leiden, The Netherlands 3 Rheumatology Department, Maastricht University Medical Center, Maastricht, The Netherlands Background The ...
BMJ1d
Assessment of enthesitis in ankylosing spondylitis
1 Department of Internal Medicine, Division of Rheumatology, University Hospital Maastricht, Maastricht, The Netherlands 2 Department of Rheumatology, Maasland Hospital Sittard, The Netherlands 3 ...
BMJ1d
AB1000 EFFECT OF THE LIPAT KALINGA ADOLESCENT TRANSITION CLINIC ON FILIPINO ADOLESCENTS WITH RHEUMATIC DISEASES
Background: Establishing a transition program is important in bridging the gap between pediatric and adult healthcare especially in patients with chronic diseases. The Division of Pediatric ...
BMJ2d
Novel ultrasonographic Halo Score for giant cell arteritis: assessment of diagnostic accuracy and association with ocular ischaemia
Objectives Ultrasound of temporal and axillary arteries may reveal vessel wall inflammation in patients with giant cell arteritis (GCA). We developed a ultrasound scoring system to quantify the extent ...
BMJ3d
Genetics of rheumatoid arthritis: 2018 status
Study of the genetics of rheumatoid arthritis (RA) began about four decades ago with the discovery of HLA-DRB1. Since the beginning of this century, a number of non-HLA risk loci have been identified ...
BMJ2d
Efficacy and safety of emapalumab in macrophage activation syndrome
Objectives Macrophage activation syndrome (MAS) is a severe, life-threatening complication of systemic juvenile idiopathic arthritis (sJIA) and adult-onset Still’s disease (AOSD). The objective of ...
BMJ5d
Risk of venous thromboembolism in rheumatoid arthritis, and its association with disease activity: a nationwide cohort study from Sweden
Objective To assess the incidence of venous thromboembolism (VTE) in rheumatoid arthritis (RA) relative to individuals without RA, and to investigate the relationship between aspects of clinical ...
BMJ1d
Inequities in access to biologic and synthetic DMARDs across 46 European countries
1 Department of Health Promotion and Education, Maastricht University, School for Public Health and Primary Care (CAPHRI), Maastricht, The Netherlands 2 Department of Rheumatology, Hospital Garcia de ...
BMJ4d
Onset of rheumatoid arthritis after COVID-19: coincidence or connected?
Correspondence to Veerle F A M Derksen, Rheumatology, Leiden University Medical Center, Leiden 2300 RC, Netherlands; v.f.a.m.derksen{at}lumc.nl If you wish to reuse ...